Percheron Therapeutics Limited (ASX: PER)
Sector: Health Care
Market cap: A$6M (as of 2 Nov 2026)
Percheron Therapeutics is a clinical-stage biotechnology company advancing first-in-class immuno-oncology therapies to tackle some of the most difficult-to-treat cancers
Data as of 2 Nov 2026.
Recent capital raises
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 28 Aug 2025 | MUTUAL INVESTMENTS PTY LTD | Unknown | — | Filing ↗ |
| 5 Mar 2025 | Gregory Norman Peters and each of the persons named in Annexure A | Exit | — | Filing ↗ |
| 7 Jan 2025 | Gregory Norman Peters | Entry | ?% → 5.100% | Filing ↗ |
| 19 Dec 2024 | Platinum Asset Management Investment Management Ltd | Decrease | ?% → 9.200% | Filing ↗ |
| 15 Nov 2024 | Platinum Asset Management Investment Management Ltd | Decrease | ?% → 9.570% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 22 Dec 2025 | Ben Gil Price | Bought 2,000,000 fully paid ordinary shares | Filing ↗ |
| 17 Dec 2025 | Dr James Garner | Bought 1,000,000 fully paid ordinary shares | Filing ↗ |
| 30 June 2025 | Dr James Garner | Bought 2,500,000 | Filing ↗ |
| 31 Mar 2025 | Ben Gil Price | Bought 5,000,000 fully paid ordinary shares | Filing ↗ |
| 26 Mar 2025 | Dr James Garner | Bought 7,500,000 | Filing ↗ |
Cash and runway
Ask about PER in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has PER raised money in the last year, and at what discount?
- What was PER's latest cash position and runway?
Loading PER…